Regulatory T cells: masterminds of immune equilibrium and future therapeutic innovations

被引:1
作者
Ge, Junwei [1 ,2 ,3 ]
Yin, Xuan [1 ,2 ,3 ]
Chen, Lujun [1 ,2 ,3 ]
机构
[1] Soochow Univ, Dept Tumor Biol Treatment, Affiliated Hosp 3, Changzhou, Jiangsu, Peoples R China
[2] Soochow Univ, Jiangsu Engn Res Ctr Tumor Immunotherapy, Affiliated Hosp 3, Changzhou, Jiangsu, Peoples R China
[3] Soochow Univ, Affiliated Hosp 3, Inst Cell Therapy, Changzhou, Jiangsu, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
基金
中国国家自然科学基金;
关键词
Treg; autoimmune diseases; cancer; immunotherapy; checkpoint inhibitors; 1ST-LINE PEMBROLIZUMAB; TREG DIFFERENTIATION; FOXP3; EXPRESSION; DENDRITIC CELLS; LUNG-CANCER; IMMUNOTHERAPY; NIVOLUMAB; EXPANSION; COMBINATION; SUPPRESSION;
D O I
10.3389/fimmu.2024.1457189
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Regulatory T cells (Tregs), a subset of CD4+T cells marked by the expression of the transcription factor forkhead box protein 3 (Foxp3), are pivotal in maintaining immune equilibrium and preventing autoimmunity. In our review, we addressed the functional distinctions between Foxp3+Tregs and other T cells, highlighting their roles in autoimmune diseases and cancer. We uncovered the dual nature of Tregs: they prevented autoimmune diseases by maintaining self-tolerance while contributing to tumor evasion by suppressing anti-tumor immunity. This study underscored the potential for targeted therapeutic strategies, such as enhancing Treg activity to restore balance in autoimmune diseases or depleting Foxp3+Tregs to augment anti-tumor immune responses in cancer. These insights laid the groundwork for future research and clinical applications, emphasizing the critical role of Foxp3+Tregs in immune regulation and the advancement of next-generation immunotherapies.
引用
收藏
页数:17
相关论文
共 143 条
[1]   Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression [J].
Aguilar, E. J. ;
Ricciuti, B. ;
Gainor, J. F. ;
Kehl, K. L. ;
Kravets, S. ;
Dahlberg, S. ;
Nishino, M. ;
Sholl, L. M. ;
Adeni, A. ;
Subegdjo, S. ;
Khosrowjerdi, S. ;
Peterson, R. M. ;
Digumarthy, S. ;
Liu, C. ;
Sauter, J. ;
Rizvi, H. ;
Arbour, K. C. ;
Carter, B. W. ;
Heymach, J. V. ;
Altan, M. ;
Hellmann, M. D. ;
Awad, M. M. .
ANNALS OF ONCOLOGY, 2019, 30 (10) :1653-1659
[2]   Regulatory T Cells in Skin Facilitate Epithelial Stem Cell Differentiation [J].
Ali, Niwa ;
Zirak, Bahar ;
Rodriguez, Robert Sanchez ;
Pauli, Mariela L. ;
Hong-An Truong ;
Lai, Kevin ;
Ahn, Richard ;
Corbin, Kaitlin ;
Lowe, Margaret M. ;
Scharschmidt, Tiffany C. ;
Taravati, Keyon ;
Tan, Madeleine R. ;
Ricardo-Gonzalez, Roberto R. ;
Nosbaum, Audrey ;
Bertolini, Marta ;
Liao, Wilson ;
Nestle, Frank O. ;
Paus, Ralf ;
Cotsarelis, George ;
Abbas, Abul K. ;
Rosenblum, Michael D. .
CELL, 2017, 169 (06) :1119-+
[3]   Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance [J].
Alvarez-Sanchez, Nuria ;
Cruz-Chamorro, Ivan ;
Lopez-Gonzalez, Antonio ;
Utrilla, Jose C. ;
Fernandez-Santos, Jose M. ;
Martinez-Lopez, Alicia ;
Lardone, Patricia J. ;
Guerrero, Juan M. ;
Carrillo-Vico, Antonio .
BRAIN BEHAVIOR AND IMMUNITY, 2015, 50 :101-114
[4]   Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer [J].
Andre, Fabrice ;
Ciruelos, Eva ;
Rubovszky, Gabor ;
Campone, Mario ;
Loibl, Sibylle ;
Rugo, Hope S. ;
Iwata, Hiroji ;
Conte, Pierfranco ;
Mayer, Ingrid A. ;
Kaufman, Bella ;
Yamashita, Toshinari ;
Lu, Yen-Shen ;
Inoue, Kenichi ;
Takahashi, Masato ;
Papai, Zsuzsanna ;
Longin, Anne-Sophie ;
Mills, David ;
Wilke, Celine ;
Hirawat, Samit ;
Juric, Dejan .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (20) :1929-1940
[5]   Expansion of CD25-Negative Forkhead Box P3-Positive T Cells during HIV and Mycobacterium tuberculosis Infection [J].
Angerami, Matias T. ;
Suarez, Guadalupe V. ;
Vecchione, Maria B. ;
Laufer, Natalia ;
Ameri, Diego ;
Ben, Graciela ;
Perez, Hector ;
Sued, Omar ;
Salomon, Horacio ;
Quirogal, Maria F. .
FRONTIERS IN IMMUNOLOGY, 2017, 8
[6]   Novel small molecule IL-6 inhibitor suppresses autoreactive Th17 development and promotes Treg development [J].
Aqel, S. I. ;
Kraus, E. E. ;
Jena, N. ;
Kumari, V. ;
Granitto, M. C. ;
Mao, L. ;
Farinas, M. F. ;
Zhao, E. Y. ;
Perottino, G. ;
Pei, W. ;
Lovett-Racke, A. E. ;
Racke, M. K. ;
Fuchs, J. R. ;
Li, C. ;
Yang, Y. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2019, 196 (02) :215-225
[7]   First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study [J].
Balar, Arjun V. ;
Castellano, Daniel ;
O'Donnell, Peter H. ;
Grivas, Petros ;
Vuky, Jacqueline ;
Powles, Thomas ;
Plimack, Elizabeth R. ;
Hahn, Noah M. ;
de Wit, Ronald ;
Pang, Lei ;
Savage, Mary J. ;
Perini, Rodolfo F. ;
Keefe, Stephen M. ;
Bajorin, Dean ;
Bellmunt, Joaquim .
LANCET ONCOLOGY, 2017, 18 (11) :1483-1492
[8]   Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors [J].
Balmanoukian, Ani S. ;
Infante, Jeffrey R. ;
Aljumaily, Raid ;
Naing, Aung ;
Chintakuntlawar, Ashish V. ;
Rizvi, Naiyer A. ;
Ross, Helen J. ;
Gordon, Michael ;
Mallinder, Philip R. ;
Elgeioushi, Nairouz ;
Gonzalez-Garcia, Ignacio ;
Standifer, Nathan ;
Cann, Jennifer ;
Durham, Nicholas ;
Rahimian, Shahram ;
Kumar, Rakesh ;
Denlinger, Crystal S. .
CLINICAL CANCER RESEARCH, 2020, 26 (23) :6196-6203
[9]   Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism [J].
Ban, Liqin ;
Zhang, Jack ;
Wang, Limei ;
Kuhtreiber, Willem ;
Burger, Douglas ;
Faustman, Denise L. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (36) :13644-13649
[10]   Induction of regulatory T cells and efficacy of low-dose interleukin-2 in systemic sclerosis: interventional open-label phase 1-phase 2a study [J].
Barde, Francois ;
Lorenzon, Roberta ;
Vicaut, Eric ;
Riviere, Sebastien ;
Cacoub, Patrice ;
Cacciatore, Carlotta ;
Rosenzwajg, Michelle ;
Daguenel-Nguyen, Anne ;
Fain, Olivier ;
Klatzmann, David ;
Mekinian, Arsene .
RMD OPEN, 2024, 10 (02)